Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-28
DOI
10.3389/fphar.2021.668825
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
- (2021) Hengwei Wu et al. JAMA Network Open
- Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation
- (2020) Yanmin Zhao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ruxolitinib combined with etanercept induce a rapid response to corticosteroid‐refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi‐center prospective study
- (2020) Yanmin Zhao et al. AMERICAN JOURNAL OF HEMATOLOGY
- Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome
- (2019) Wang-Chun Kwok et al. RESPIROLOGY
- Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation
- (2019) Michelle Schoettler et al. BONE MARROW TRANSPLANTATION
- Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease
- (2019) Christopher Streiler et al. BONE MARROW TRANSPLANTATION
- Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
- (2019) Virginia Escamilla Gómez et al. BONE MARROW TRANSPLANTATION
- Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions
- (2018) Mehrdad Hefazi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease
- (2018) Hanna Jean Khoury et al. BONE MARROW TRANSPLANTATION
- Lung transplantation after allogeneic stem cell transplantation: a pan-European experience
- (2018) Mark Greer et al. EUROPEAN RESPIRATORY JOURNAL
- Repression of interferon β-regulated cytokines by the JAK1/2 inhibitor ruxolitinib in inflammatory human macrophages
- (2018) Marie Febvre-James et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Effect of Azithromycin on Airflow Decline–Free Survival After Allogeneic Hematopoietic Stem Cell Transplant
- (2017) Anne Bergeron et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Imatinib ameliorates bronchiolitis obliterans via inhibition of fibrocyte migration and differentiation
- (2017) Satoshi Watanabe et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease
- (2017) Kyle R. Brownback et al. LUNG
- Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation
- (2016) Kirsten M. Williams et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner
- (2016) Cameron McDonald-Hyman et al. BLOOD
- How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
- (2016) Kirsten M. Williams BLOOD
- Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice
- (2016) Sophia Maschalidi et al. BLOOD
- Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation
- (2016) C Del Fante et al. BONE MARROW TRANSPLANTATION
- Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation
- (2015) Anne Bergeron et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
- (2015) S Watanabe et al. BONE MARROW TRANSPLANTATION
- JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
- (2015) Kathrin Schönberg et al. CANCER RESEARCH
- Prognostic role of FEV1for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation
- (2015) Jee Hwan Ahn et al. CLINICAL TRANSPLANTATION
- Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
- (2015) R Zeiser et al. LEUKEMIA
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- Obliterative Bronchiolitis
- (2014) Alan F. Barker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
- (2014) Jaebok Choi et al. PLoS One
- CXCR3 Ligands Are Associated with the Continuum of Diffuse Alveolar Damage to Chronic Lung Allograft Dysfunction
- (2013) Michael Y. Shino et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
- (2013) A. Heine et al. BLOOD
- Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?
- (2013) A. Heine et al. BLOOD
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gram-Negative Infection and Bronchiectasis in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome
- (2012) Aaron Weiland et al. THORACIC AND CARDIOVASCULAR SURGEON
- Lung Transplantation for Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
- (2012) Ursula M. Vogl et al. TRANSPLANTATION
- Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation
- (2011) Gregory A. Yanik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bronchiolitis Obliterans Syndrome Epidemiology after Allogeneic Hematopoietic Cell Transplantation
- (2010) Brandon K.C. Au et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT
- (2010) C E Lucid et al. BONE MARROW TRANSPLANTATION
- Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation—An Increasingly Recognized Manifestation of Chronic Graft-versus-Host Disease
- (2009) Jason W. Chien et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
- (2009) Kirsten M. Williams JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now